Processa Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Processa Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Processa Pharmaceuticals Inc
Rating: 0.87650
Author: Trendlyne DVM scores

about

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is...

3.92 0.41 (11.68%)

85.48% Fall from 52W High

246.0K

XNAS Volume

XNAS 26 Dec, 2025 4:30 PM (EST)

Not Eligible

Expensive Valuation

11.5 / 100

Technically Bearish

23.6 / 100

No estimates available

Processa Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Processa Pharma Inc Live Stock Price Today, Share Analysis and Chart

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is...

85.48% Fall from 52W High

SWOT Analysis

Processa Pharma Inc Live Price Chart